7th January 2020
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
2nd December 2019
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
13th November 2019
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
4th September 2019
Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)
9th January 2019
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
3rd January 2019
Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
27th August 2018
Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
10th May 2018
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
2nd May 2018
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
11th April 2018
Curium to acquire the French commercial and manufacturing operations of Cyclopharma
28th January 2018
Curium One-Year Anniversary Marked by Landmark Achievements
16th January 2018
Curium Is the First North American Manufacturer Offering Exclusively 100% LEU Generators
18th December 2017
Curium’s Renaud Dehareng receives top USA CEO award 2017!
6th April 2017
IBA Molecular and Mallinckrodt Nuclear Medicine LLC to create a new, world-class radiopharmaceutical company: Curium
27th January 2017
IBA Molecular acquires Mallinckrodt Nuclear Imaging to create world-class radiopharmaceuticals Group
24th August 2016